Scuola di Specializzazione in Igiene e Medicina Preventiva, Università of Perugia, Perugia, Italy.
Azienza USL Umbria 1, Dipartimenti di Prevenzione, Servizio di Epidemiologia, Perugia, Italy.
Ann Ist Super Sanita. 2023 Jan-Mar;59(1):10-25. doi: 10.4415/ANN_23_01_03.
Vaccine hesitancy is a major public health issue and a challenge for the implementation of COVID-19 immunization campaigns. The objective of this study was to address the determinants of COVID-19 vaccination acceptance or hesitancy in the Italian population.
We conducted a rapid systematic review by searching PubMed until May 3rd, 2022, according to Preferred Reporting Items for Systematic Reviews (PRISMA) guidelines. Articles assessing determinants of Italians' attitudes towards COVID-19 vaccination in terms of hesitancy and/or acceptance were considered eligible. Quality and risk of bias assessment was performed through the Newcastle Ottawa Scale appraisal tool. Determinants were grouped in three categories: contextual, individual and group, and vaccine/vaccination specific influences.
Out of 606 articles, 59 studies were included in the analysis. Included studies demonstrated that, in Italy, COVID-19 vaccination acceptance or hesitancy is mostly influenced by perceived safety, efficacy and usefulness of the vaccine.
These findings should be considered to plan tailored interventions for counteracting COVID-19 vaccination hesitancy in Italy.
疫苗犹豫是一个主要的公共卫生问题,也是 COVID-19 免疫接种活动实施的一个挑战。本研究的目的是确定意大利人群中 COVID-19 疫苗接种接受或犹豫的决定因素。
我们根据系统评价报告的首选项目(PRISMA)指南,在 PubMed 上进行了快速系统评价检索,直至 2022 年 5 月 3 日。评估意大利人对 COVID-19 疫苗接种的态度(犹豫和/或接受)的决定因素的文章被认为是合格的。通过纽卡斯尔-渥太华量表评估工具进行质量和偏倚风险评估。决定因素分为三类:背景、个体和群体,以及疫苗/接种特异性影响。
在 606 篇文章中,有 59 篇被纳入分析。纳入的研究表明,在意大利,COVID-19 疫苗接种的接受或犹豫主要受到疫苗的安全性、有效性和有用性的影响。
这些发现应被视为在意大利制定有针对性的干预措施以对抗 COVID-19 疫苗犹豫的依据。